🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of the trial are to demonstrate the safety and performance o...
Status
Unknown
Location
Australian Clinical Trials
Start Date
2019-01-16
Trial ID
NCT03577236
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2019-04-01
Trial ID
NCT04534634
Treatments Being Tested
This clinical trial aims to evaluate the safety and feasibility of mid-line...
Status
Completed
Location
Samsung Medical Center
Start Date
2021-06-01
Trial ID
NCT05872334
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
The purpose of the study is to evaluate the safety and tolerability of sing...
Status
Completed
Location
SGS Stuivenberg
Start Date
2009-12
Trial ID
NCT01023321
CTQJ230A1US13 is a randomized, double-blind, placebo-controlled, multicente...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07625306
Treatments Being Tested
This study will evaluate the percentage change from baseline in weight afte...
Status
Completed
Location
Handan First Hospital
Start Date
2024-08-14
Trial ID
NCT07020884
Treatments Being Tested
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics o...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2024-04-10
Trial ID
NCT06344533
Treatments Being Tested
The objectives of the study are to assess the safety and tolerability of a ...
Status
Completed
Location
Ironwood Investigational Site
Start Date
2015-10
Trial ID
NCT02572349
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested